Clobet Cream Special Precautions

Local irritation: If local irritation develops, discontinue use and institute appropriate therapy.
Atrophic change: Certain areas of the body, such as the face, groin and axillae, are more prone to atrophic changes than other areas of the body following treatment with corticosteroids.
Psoriasis: Do not use topical corticosteroids as sole therapy in widespread plaque psoriasis.
Infections: In the presence of an infection, institute therapy with an antifungal or antibacterial agent. If a favorable response does not occur promptly, discontinue the corticosteroid until the infection has been controlled.
Use in Children: Children may be more susceptible to topical corticosteroid-induced hypothalamic-pituitary-adrenal (HPA) axis suppression and Cushing's syndrome than adults because of a larger skin surface area to body weight ratio. Limit administration to the least amounts compatible with effective therapy. Chronic corticosteroid therapy may interfere with the growth and development of children.
Because certain areas of the body may be more susceptible to atrophic changes than others following treatment with corticosteroids, clobetasol propionate cream should not be applied to the face or intertriginous areas. Clobetasol propionate cream should not be used with occlusive dressings (including bandages).